Health-Ecore news

Read our latest updates here.

Vaccination

2 min read

Adjuvanted influenza vaccine is a cost-effective investment for older adults in the Netherlands

Replacing standard-dose with adjuvanted influenza vaccination in adults aged 60 and over, and in high-risk adults aged 50–59, could prevent hundreds...

Read More

2 min read

High-dose influenza vaccination remains a cost-effective investment for older adults in the Netherlands

Updated health-economic evidence, drawing on data from more than 85 million individuals, confirms that switching from standard-dose to high-dose...

Read More

2 min read

What Delayed RSV Vaccination Is Costing the Netherlands

Every winter, the Respiratory Syncytial Virus (RSV) fills hospital wards. Around 6,000 older adults are admitted with RSV infection in the...

Read More

2 min read

The Value of Efforts to Increase Vaccination Uptake in the Netherlands

Vaccination prevents disease, reduces societal costs, and, when coverage is high enough, eliminates the threat of outbreaks entirely. Yet in the...

Read More

1 min read

RSV vaccination: a cost-effective strategy for older adults in the Netherlands

Respiratory Syncytial Virus (RSV) is increasingly recognized as a serious health threat for older adults. In the Netherlands, RSV may lead to...

Read More

1 min read

Launch of the vaccination guideline for adults with chronic lung disease

On World Lung Day, the Long Alliantie Nederland introduced the first national vaccination guideline for adults with chronic lung disease. Developed...

Read More

Cover photo: Chris Bonis